SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-06-001504
Filing Date
2006-06-12
Accepted
2006-06-12 17:19:12
Documents
8
Period of Report
2006-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 dp02810_8k.htm 8-K 16715
2 dp02810-ex0401.htm EX-4.1 513519
3 GRAPHIC gp02810-ex0401x66x1.jpg GRAPHIC 4467
4 GRAPHIC gp02810-ex0401x66x2.jpg GRAPHIC 5800
5 GRAPHIC gp02810-ex0401x67x1.jpg GRAPHIC 5478
6 GRAPHIC p61.jpg GRAPHIC 2874
7 GRAPHIC p63.jpg GRAPHIC 2332
8 GRAPHIC p64.jpg GRAPHIC 3415
  Complete submission text file 0000950103-06-001504.txt   566466
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 06900569
SIC: 2836 Biological Products, (No Diagnostic Substances)